Filter
1953
Filtered Results: 1953
Text search:
trials
guidelines
Featured
Recommendations
210
New Publications
376
Language
Document type
No document type
1060
Guidelines
375
Studies & Reports
301
Manuals
93
Strategic & Response Plan
44
Fact sheets
35
Training Material
23
Situation Updates
8
Infographics
6
Resource Platforms
5
Brochures
2
Videos
1
Countries / Regions
India
107
Global
81
South Africa
54
Kenya
41
Western and Central Europe
33
Africa
28
Nigeria
23
Ethiopia
23
Uganda
22
Sierra Leone
19
Zambia
19
Nepal
17
Tanzania
17
Malawi
17
Eastern Europe
16
Russia
16
Philippines
15
Brazil
15
Latin America and the Carribbean
15
Liberia
14
Ghana
14
Ukraine
14
Zimbabwe
13
Rwanda
13
Indonesia
13
East and Southern Africa
12
Bangladesh
11
West and Central Africa
11
South–East Asia Region
11
Asia
11
Namibia
10
Congo, Democratic Republic of
8
South Sudan
8
Mozambique
8
Lesotho
7
USA
6
Cameroon
6
Germany
6
Syria
6
Eswatini/ Swaziland
6
Colombia
6
Botswana
6
Guinea
5
Senegal
5
Cambodia
5
Thailand
5
Peru
5
Myanmar / Burma
5
Middle East and North Africa
5
Eastern Europe and Central Asia
5
Burkina Faso
4
Haiti
4
Argentina
4
Albania
4
United Kingdom
4
Guinea-Bissau
3
Lebanon
3
Sudan
3
Angola
3
Georgia
3
Vietnam
3
North America
3
Spain
3
Morocco
2
Pakistan
2
Iraq
2
China
2
Burundi
2
Mexico
2
Sri Lanka
2
Western Pacific Region
2
Paraguay
2
Venezuela
2
Laos
2
Tajikistan
2
Estonia
2
Iran
2
Kyrgyzstan
2
Portugal
2
Mali
1
Côte d’Ivoire / Ivory Coast
1
Saudi Arabia
1
Somalia
1
Jordan
1
Afghanistan
1
Turkey
1
Egypt
1
Singapore
1
Benin
1
Central African Republic
1
North Macedonia
1
Hungary
1
Ecuador
1
Greece
1
Madagascar
1
Chile
1
Bulgaria
1
Kazakhstan
1
Jamaica
1
Denmark
1
France
1
Tunisia
1
Norway
1
Authors & Publishers
Publication Years
Category
Countries
500
Clinical Guidelines
322
Public Health
152
Women & Child Health
128
Key Resources
41
Pharmacy & Technologies
27
Capacity Building
23
Toolboxes
Mental Health
243
HIV
222
COVID-19
172
TB
167
NCDs
87
AMR
60
NTDs
59
Caregiver
53
Pharmacy
46
Rapid Response
45
Ebola
36
Planetary Health
32
Disability
25
Conflict
21
Refugee
17
Global Health Education
15
Polio
12
Zika
9
Cholera
7
Natural Hazards
6
Specific Hazards
5
Social Ethics
4
Health Financing Toolbox
4
Updated recommendations on treatment of adolescents and children with chronic HCV infection
recommended
The new treatment recommendations that extend the 2018 treat all recommendation for adults with chronic HCV infection to include adolescents and children down to 3 years, and to align the existing recommended pangenotypic direct-acting antiviral (DAA) regimens (SOF/DCV, SOF/VEL and G/P) for adults, ...
This report’s central premise is that diagnostics and therapeutics, and associated test to treat strategies, are fundamental components of the pandemic response, both for COVID-19 and for future health threats. Two years into the COVID-19 pandemic, this report reflects on the main challenges and k...
Schools are generally the most popular setting for drug-use-
prevention programmes, and are used both by governmental and
non-governmental agencies. This may be for many reasons: ease of
obtaining funding for school drug-use-prevention programmes, the
captive audience, and the popular perception...
January 2020 to December 2021
Trachoma causes more vision loss and blindness than any other infection in the world. This disease is caused by Chlamydia trachomatis bacteria. Other variants or strains of these bacteria can cause a sexually transmitted infection (chlamydia) and disease in lymph nodes.
This is photomicrograph ...
PLoS Neglected Tropical diseases August 16, 2021 https://doi.org/10.1371/journal.pntd.0009697
Chagas disease, also known as American trypanosomiasis, is a neglected tropical disease transmitted by triatomine insects, first identified in 1909. Chagas disease affects approximately 6–7 million peop...
This report provides a review and analysis of the research landscape for three diseases – Chagas disease, human African trypanosomiasis and leishmaniasis – that disproportionately afflict poor and remote populations with limited access to health services. It represents the work of the disease re...
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The patient-centred platform aims to f...
This sourcebook aims to detail why health needs to be part of urban and territorial planning and how to make this happen. It brings together two vital elements we need to build habitable cities on a habitable planet: 1) Processes to guide the development of human settlements – in this document ref...
PLoS Negl Trop Dis 15(8): e0009697. Chagas disease (CD), caused by the parasite Trypanosoma cruzi, affects ~6–7 million people worldwide. Significant limitations still exist in our understanding of CD. Harnessing individual participant data (IPD) from studies could support more in-depth analyses t...
Research and Reports in Tropical Medicine 2022:13 25–40.
Chagas disease (CD) is caused by the parasite Trypanosoma cruzi, and it is endemic in Central, South America, Mexico and the South of the United States. It is an important cause of early mortality and morbidity, and it is associated with po...
Regional implementation framework for elimination of cervical cancer as a public health problem: 2021–2030
recommended
Cervical cancer continues to be a significant public health problem and a major cause of premature mortality among women, disproportionately affecting the socioeconomically disadvantaged population in low- and middle-income countries (LMICs). In the absence of implementing the known evidence-based, ...
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f...
The annual Joint Meeting of the Food and Agriculture Organization of the United Nations (FAO) Panel of Experts on Pesticide Residues in Food and the Environment and the World Health Organization (WHO) Core Assessment Group on Pesticide Residues (JMPR) was held in Rome, Italy, from 13 to 22 September...
Report of a global meeting on yaws eradication surveillance, monitoring and evaluation: Geneva, 29–30 January 2018. World Health Organization.
Presentation on WASH in Malawi
The KMC implementation strategy targets a broad audience. These include policy-makers and programme managers at national, regional and local levels, government and nongovernmental organizations working in the area of maternal and newborn care, global and national professional associations, public an...
This report compiles data for the first time on the far-reaching consequences of uncontrolled hypertension, including heart attacks, strokes and premature death, along with substantial economic losses for communities and countries. It also contains information on the global, regional and country-lev...
WHO today released its first roadmap to tackle postpartum haemorrhage (PPH) – defined as excessive bleeding after childbirth - which affects millions of women annually and is the world’s leading cause of maternal deaths.
Despite being preventable and treatable, PPH results in around 70 000 de...
The Coronavirus Disease 2019 (COVID-19) has had a continuous and robust impact on world health. The resulting COVID-19 pandemic has had a devastating physical, mental and fiscal impact on the millions of people living with noncommunicable diseases (NCDs), as they have a higher risk of severe illness...
